Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Innovation Action · Running

AIRCARE AI-augmented Robotics for CAncer point of caRE

Coordinator
Fondazione Istituto Italiano Di Tecnologia, Italy
Runs
1 July 2024 to 30 June 2028
Status
Running
EU funding
€7.9m
Total cost
€8.5m
Partners
14 organisations in 6 countries
Type
Innovation Action
Grant agreement
101137426

What the project is doing

In the project's own words, from its summary on CORDIS.

Cancer in the Upper Aerodigestive Tract (UADT) is still among the leading cancer types worldwide, with both incidence rate and mortality rate constantly rising. Treatment of these diseases is by Ear-Nose-Throat (ENT) surgeons, operating with incomplete knowledge of the tumor geometry, under non-ergonomic conditions and with limited precision on fragile cancerous tissue. AIRCARE will bring clinical practice in diagnosis and surgical treatment to the next level, by introducing advanced AI and robotic technology into the clinical workflow.

For diagnosis, AIRCARE will enable real-time on-the-spot AI-powered optical/electric biopsies, helping to optimize a patient-specific surgical approach. For surgery, AIRCARE will provide a more controlled and ergonomic setting. Novel robotic stabilizing and controlling tools will further allow manipulation of tissue and removal of cancer with unprecedented levels of precision. A newly developed intuitive 3D visualization will simplify the understanding of the complex surgical scene.

Aside from increase of safety, quality and efficiency of the surgical procedure, also less experienced surgeons may become able to perform complex image guided treatments. Within this innovation action, our European partners spanning universities, research centers, industry and 3 hospitals, will join forces across disciplines to advance promising research prototypes into two advanced integrated systems: one for diagnosis, one for surgery, thus supporting clinicians from the detection and diagnosis of UADT diseases until their surgical treatment.

Within the framework of the project, the superiority of AIRCARE technology will be demonstrated in real operational environments through three clinical studies. By doing so, we aim to demonstrate the benefits of AI and robotics to healthcare professionals and UADT patients and put the seeds to translate this technology into the next standard of care for improved clinical outcomes.

Topics

Who is involved

OrganisationCityCountryRole
Fondazione Istituto Italiano Di TecnologiaGenovaItalyCoordinator
Acmit GmbHWiener NeustadtAustriaParticipant
Barco NVKortrijkBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
TimelexBruxelles / BrusselBelgiumParticipant
Syddansk UniversitetOdense MDenmarkParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Inventya Ventures (EU) LimitedDublinIrelandParticipant
Barco SRLSaronnoItalyThird party
El.en.-SpaCalenzano FiItalyParticipant
Scuola Superiore Di Studi Universitari E Di Perfezionamento S AnnaPisaItalyParticipant
Universita Degli Studi Di GenovaGenovaItalyParticipant
Universita Degli Studi Gabriele D'annunzio Di Chieti-PescaraChietiItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI